drugset / Trial / NCT03385967
Duration of Analgesia With Dexmedetomidine and Ropivacaine in Brachial Plexus Block
RandomizedParallel-groupDouble-blindTreatment
Summary
This is a prospective, randomized, double blind study of adding dexmedetomidine to ropivacaine for Brachial plexus block and assessing the analgesia with VAS pain scales(0-10), Satisfaction scale by VAS scale(0-10) and time to first analgesic consumption. This study mainly aims to investigate whether addition of dexmedetomidine helps in increasing the duration of analgesia.
Timeline
- Start
- 2019-04
- Primary completion
- 2019-12
- Completion
- 2019-12
Outcome
Outcome not reported
Stopped: “PI is leaving the University of Florida”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Dexmedetomidine | Other / unclassified | 0.25 ug/kg | Other |
| Comparator | Ropivacaine | Other / unclassified | 0.5 % | Other |
| Comparator | Ropivacaine | Other / unclassified | 25 ml | Other |
Indications
No indication recorded.